Disclosure: This post contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Sermorelin therapy means taking sermorelin, a synthetic peptide that signals the pituitary gland to release growth hormone, under a prescription. It was once an FDA approved drug for children with a growth hormone deficiency. Today it is available mainly as a compounded medicine, and the adult wellness uses clinics promote are not FDA approved.
I’m Judy, and I’m not a doctor. My experience, not medical advice: I started GLP-1 injections in May 2024 at age 47. This page is a research summary built from FDA pages and published studies that I link, not a personal review of sermorelin, so please take your questions to a licensed clinician.
What is sermorelin therapy?
Sermorelin is a 29 amino acid analog of growth hormone releasing hormone, or GHRH. A published review describes it as the shortest synthetic peptide with the full biological activity of GHRH, and says it stimulates growth hormone release from the anterior pituitary (Prakash and Goa, BioDrugs, 1999).
That makes it different from human growth hormone (HGH) itself. HGH is the hormone. Sermorelin is a signal sent to the gland that makes it. Clinics and telehealth services use the phrase “sermorelin therapy” for a prescribed treatment, and the company page I quote below lists injection, troche and film strip forms.
How does sermorelin work in the body?
The review above says sermorelin specifically stimulates growth hormone secretion from the anterior pituitary. In a trial of a close relative of sermorelin, a nightly injection triggered a release of growth hormone within 10 minutes that lasted about 2 hours (Khorram et al., Journal of Clinical Endocrinology and Metabolism, 1997).
Raising growth hormone is not the same as improving how you feel or look. Whether that release turns into better sleep, recovery or body composition is the open question, and the research section below covers it.
Is sermorelin therapy FDA approved?
Sermorelin was FDA approved once, for narrow uses, and that approval is gone. The adult wellness uses that clinics promote today were never approved.
What was Geref approved for?
A Federal Register notice published March 4, 2013 explains that Geref (sermorelin acetate) from EMD Serono had two applications. The injectable vials, NDA 20-443, were approved on September 26, 1997 and were “indicated for the treatment of idiopathic growth hormone deficiency (GHD) in children with growth failure.” The ampule, NDA 19-863, was approved on December 28, 1990 to evaluate whether the pituitary gland can secrete growth hormone (Federal Register).
An FDA briefing for its October 29, 2024 compounding advisory committee puts the adult picture plainly: only sermorelin (Geref) was approved for short stature from growth hormone deficiency in children, and no growth hormone secretagogue is approved for growth hormone deficiency in adults (FDA PCAC briefing document).
Why is Geref no longer sold?
The same Federal Register notice says the manufacturer discontinued the vials and asked FDA to withdraw the application, and that FDA withdrew approval of both applications effective June 18, 2009. FDA also determined the products “were not withdrawn from sale for reasons of safety or effectiveness.” The Drugs@FDA listing for NDA 020443, which I read on October 20, 2026, shows both strengths as discontinued (Drugs@FDA).
A search of DailyMed, the National Library of Medicine’s drug label database, for “sermorelin” on October 20, 2026 returned no drug package labels (DailyMed search). So there is no current approved product label to read, the way there is for Wegovy or Ozempic.
What is compounded sermorelin?
Compounded sermorelin is made by a compounder such as a licensed pharmacy rather than by a drug company under an FDA approval. It is not Geref. FDA states that compounded drugs are not FDA approved and that it does not check their safety, effectiveness or quality before they are sold, and it says state boards of pharmacy generally oversee state licensed pharmacies that are not registered outsourcing facilities (FDA compounding Q&A, current as of September 2025).
In practice, the quality of what you receive depends on the pharmacy that makes it. Ask any provider which pharmacy fills the prescription and whether it is licensed in your state.
Where does sermorelin stand on FDA’s compounding lists?
Under section 503A, as FDA’s January 2025 guidance describes it, a licensed pharmacist or physician may compound with a bulk drug substance that follows a USP or NF monograph, is a component of an FDA approved drug, or appears on the 503A bulks list. Under its interim policy, FDA also says it does not intend to take action when the substance is on Category 1, among other conditions (FDA interim policy guidance, January 2025). Substances nominated for that list sit in three categories. In Category 1, FDA is still evaluating the nominated substances. Category 2 means FDA has identified significant safety risks. Category 3 means the nomination lacked enough support (FDA 503A bulks page, current as of May 14, 2026).
Sermorelin is not named in FDA’s three category list updated May 14, 2026, and it is not named on FDA’s category 2 safety page current as of April 22, 2026 (FDA category list, FDA category 2 page). Those pages do not say whether a particular pharmacy may compound it, so that question belongs to the pharmacy and your state board.
What does the research say about sermorelin therapy?
The clinical evidence is old, small and mostly not about the adult wellness uses that are marketed today.
Children with growth hormone deficiency
The strongest evidence is in children. A review with limited data found that bedtime injections increased height velocity in some prepubertal children with idiopathic growth hormone deficiency, with gains sustained over 12 months. It also noted that the gains were smaller than with daily somatropin, without a direct head to head comparison, and that the effect on final adult height was not yet known (Prakash and Goa, 1999).
Older adults
One randomized, single blind, placebo controlled trial gave a modified GHRH analog, [Nle27]GHRH(1 to 29), which is a close relative of sermorelin and not sermorelin itself, to 19 adults aged 55 to 71 (10 women and 9 men). Participants had 4 weeks of placebo, then 16 weeks of the analog nightly. Nighttime growth hormone rose, and IGF-I, a related hormone, rose within 2 weeks and was reported to return toward baseline by week 16. Body weight was unaffected. Lean body mass increased in men only, and sleep quality was unaffected in both sexes (Khorram et al., 1997). That is one short study in 19 people.
A 2026 review of peptides sold as “research compounds” that act on the growth hormone axis, which names sermorelin among the GHRH analogues, points to the absence of regulatory approval for physique or performance uses. It adds that unregulated supply chains leave product composition and dose uncertain (Dominikowski et al., Frontiers in Endocrinology, 2026).
Does sermorelin therapy help with weight loss or anti-aging?
The evidence above does not show it helps with weight loss: body weight did not change. For aging, one small study of a related analog found more skin thickness in both sexes and better well-being and libido in men only, with no change in sleep quality and more lean mass in men only. One study of 19 people cannot show that sermorelin works for anti-aging. Companies selling sermorelin describe benefits for sleep, energy, recovery and muscle, but a company page is marketing, not a trial.
For example, GobyMeds lists sermorelin as an injection, troche or film strip, and its FAQ describes it as available “for off-label use via prescription for anti-aging and vitality purposes” (company page, read October 20, 2026). Off-label means outside what FDA approved.
If weight is your goal, ask your clinician about every option, because this research gives no reason to treat sermorelin as a weight loss drug.
Who prescribes sermorelin therapy?
Sermorelin is a prescription medicine, so it comes from a prescriber and a licensed pharmacy. FDA’s online pharmacy guidance says a safe online pharmacy requires a doctor’s prescription, lists a U.S. address and phone number, has a pharmacist available and is licensed by a state board of pharmacy. It names selling prescription drugs without requiring a prescription as a warning sign (FDA consumer update, current as of January 2025).
That prescriber can be your own doctor or a clinician at a telehealth service. Either way, the clinician decides whether it is appropriate for you, and a no is a normal outcome. My separate guide on how to get sermorelin walks through the legal route step by step.
Some readers want to start with a telehealth service rather than a local clinic. GobyMeds lists sermorelin among its products, and when I checked its site on October 19, 2026, every product’s Get Started button opened the same account sign-up page. That page is general. It is not a sermorelin page, and it settles nothing about sermorelin, because a licensed provider decides after a consultation. I use the affiliate code MTVN25 and may earn a commission if you sign up through this link.
GobyMeds says its sermorelin is a compounded medication prepared by a licensed pharmacy. Compounded medications are not FDA approved, a provider must approve you before anything ships, and results vary from person to person.
What are the side effects of sermorelin?
In the pediatric review, the most common adverse events were transient facial flushing and pain at the injection site, and the drug was described as well tolerated (Prakash and Goa, 1999). In the older adult trial of the related analog, the only adverse effect reported was transient hyperlipidemia, meaning raised blood fats, which resolved by the end of the study (Khorram et al., 1997).
Those studies are small and decades old, and long term safety in older adults is not established by them. Read my full sermorelin side effects page, and tell your clinician about every medicine and condition you have.
What should you ask before starting sermorelin therapy?
- Which pharmacy compounds it, and does it hold a license in my state?
- What bloodwork comes first, and who explains the results to me?
- What is the goal, and how will we measure whether it is working?
- Do my current medicines or conditions raise any risk?
- What does the full price cover, and what costs extra after month one?
Frequently Asked Questions
Is sermorelin FDA approved?
Not currently. Geref, a sermorelin product, was approved in 1997 for children with growth failure from growth hormone deficiency, and FDA withdrew that approval in 2009 after the manufacturer discontinued it. Compounded sermorelin made today is not FDA approved.
Is sermorelin illegal?
Sermorelin is supplied by prescription. The telehealth company GobyMeds says all of its prescriptions require a consultation with a licensed provider, and FDA lists selling prescription drugs without a prescription as a sign of an unsafe online pharmacy. FDA warns against buying prescription drugs without a prescription.
Does sermorelin work for weight loss?
The trial I cite found no change in body weight in adults aged 55 to 71 who took a related GHRH analog for 16 weeks. That is one small study, so it does not settle the question, but it gives no reason to treat sermorelin as a weight loss drug.
Does sermorelin work for people over 60?
The only adult trial I cite included people aged 55 to 71, and it showed growth hormone and IGF-I rising on treatment. Sleep quality did not change, lean mass rose in men only, and skin thickness rose in both sexes. Whether that matters for your health is a decision for your clinician.
Is sermorelin the same as HGH?
No. HGH is growth hormone itself. Sermorelin is a GHRH analog that prompts the pituitary gland to release your own growth hormone.
Is compounded sermorelin safe?
FDA says it does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. Safety depends on the prescriber, the pharmacy and your own health history, so ask for the pharmacy’s name and confirm its state license.
This page is general information, not medical advice. I’m not a medical professional, so talk with your doctor or prescriber before you start, change or stop any prescription, and do not buy a prescription peptide from a seller that does not require one.
Sources
- Federal Register notice on GEREF (sermorelin acetate), March 4, 2013
- Drugs@FDA, NDA 020443, read October 20, 2026
- DailyMed search for sermorelin, read October 20, 2026
- FDA briefing document for the October 29, 2024 compounding advisory committee
- FDA compounding questions page, current as of September 2025
- FDA interim policy guidance on section 503A bulk substances, January 2025
- FDA 503A bulks page, current as of May 14, 2026
- FDA category list, updated May 14, 2026
- FDA category 2 safety risks page, current as of April 22, 2026
- FDA consumer update on buying medicine online, January 2025
- Prakash and Goa, BioDrugs 1999, sermorelin in children with growth hormone deficiency
- Khorram et al., J Clin Endocrinol Metab 1997, GHRH analog in older men and women
- Dominikowski et al., Front Endocrinol 2026, peptides acting on the GH-IGF1 axis